STAGE III VAGINAL CANCER AJCC V6 AND V7
Clinical trials for STAGE III VAGINAL CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III VAGINAL CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE III VAGINAL CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of oral cancer drug seeks to boost radiation power
Disease control OngoingThis early-stage study is testing a new oral drug called Triapine, given alongside standard chemotherapy (cisplatin) and radiation for advanced cervical or vaginal cancer. The main goals are to find the safest and most effective dose of Triapine and to see how well the body absor…
Matched conditions: STAGE III VAGINAL CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for Tough-to-Treat gynecologic cancers in major national trial
Disease control OngoingThis large, late-stage trial is testing whether adding a new drug called triapine to the standard treatment of radiation and chemotherapy improves survival for women with advanced cervical or vaginal cancer. It will enroll 450 women to compare the new combination against the curr…
Matched conditions: STAGE III VAGINAL CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC